MEI Pharma opens Litecoin treasury of 110 million USD, LTC price rises by 10%

The cryptocurrency market continues to witness acceptance from public companies, with the latest positive news coming from #MEIPharma . This Nasdaq-listed pharmaceutical company has become the first U.S. public company to announce an investment in Litecoin, with a treasury fund worth 110 million USD.

Confidence in Litecoin and support from Charlie Lee

MEI Pharma stated that they purchased 929,548 $LTC at an average price of 107.58 USD. The company believes that Litecoin is a strategic asset due to its history of sustainable operations, low transaction fees, fast processing speeds, and widespread acceptance by major financial platforms such as PayPal and Robinhood.

Notably, the founder #Litecoin , Charlie Lee, will join the board of directors of MEI Pharma to advise, further reinforcing confidence in this partnership. Mr. Lee emphasized that Litecoin is an efficient digital currency with high scalability and decentralization.

Positive impact on the market

This information has created a strong bullish wave. Shares of MEI Pharma (MEIP) have risen by 95% in the past month and 5.13% on the announcement day. Meanwhile, the price of LTC has also increased by nearly 10%, reaching 128 USD, the highest level since February 2025. This move not only enhances the legitimacy of Litecoin but also indicates a trend of large companies increasingly diversifying their digital asset portfolios beyond Bitcoin and Ethereum. #anhbacong